High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis

Journal of Immunology

Volumn 192, Issue 9, 2014, Pages 4398-4408

  Yang, Aizhen ^a   Dai, Jihong ^a,b   Xie, Zhanli ^a   Colman, Robert W ^b   Wu, Qingyu ^a   Birge, Raymond B ^c   Wu, Yi ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CELL PROTEIN; COMPLEMENTARY DNA; CRK ASSOCIATED SUBSTRATE PROTEIN; DOCK 180 PROTEIN; HIGH MOLECULAR WEIGHT KININOGEN; LIPOCORTIN 5; LIPOSOME; PHOSPHATIDYLSERINE; PROTEIN CRKII; RAC1 PROTEIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL PHAGOCYTOSIS; CELL SPECIFICITY; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; EFFEROCYTOSIS; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HEK293 CELL LINE; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION; SPLENOMEGALY;

ANIMALS; APOPTOSIS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KININOGEN, HIGH-MOLECULAR-WEIGHT; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; RAC1 GTP-BINDING PROTEIN; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TRANSFECTION;

EID: 84899527153     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302590     Document Type: Article

References (53)

1. Wu, Y., N. Tibrewal, and R. B. Birge. 2006. Phosphatidylserine recognition by phagocytes: A view to a kill. Trends Cell Biol. 16: 189-197
2. Ravichandran, K. S. 2011. Beginnings of a good apoptotic meal: The find-me and eat-me signaling pathways. Immunity 35: 445-455
3. Kolodgie, F. D., J. Narula, P. Guillo, and R. Virmani. 1999. Apoptosis in human atherosclerotic plaques. Apoptosis 4: 5-10
4. Van Vré, E. A., H. Ait-Oufella, A. Tedgui, and Z. Mallat. 2012. Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32: 887-893
5. Kobayashi, N., P. Karisola, V. Peña-Cruz, D. M. Dorfman, M. Jinushi, S. E. Umetsu, M. J. Butte, H. Nagumo, I. Chernova, B. Zhu, et al. 2007. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940
6. Park, S. Y., M. Y. Jung, H. J. Kim, S. J. Lee, S. Y. Kim, B. H. Lee, T. H. Kwon, R. W. Park, and I. S. Kim. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15: 192-201
7. Wu, Y., S. Singh, M. M. Georgescu, and R. B. Birge. 2005. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J. Cell Sci. 118: 539-553
8. Mondino, A., and F. Blasi. 2004. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25: 450-455
9. Smith, H. W., and C. J. Marshall. 2010. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 11: 23-36
10. Edsfeldt, A., M. Nitulescu, H. Grufman, C. Grönberg, A. Persson, M. Nilsson, M. Persson, H. Björkbacka, and I. Gonçalves. 2012. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke 43: 3305-3312
11. Farris, S. D., J. H. Hu, R. Krishnan, I. Emery, T. Chu, L. Du, M. Kremen, H. L. Dichek, E. Gold, S. A. Ramsey, and D. A. Dichek. 2011. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: Role of the uPA receptor and S100A8/A9 proteins. J. Biol. Chem. 286: 22665-22677
12. Fuhrman, B. 2012. The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 222: 8-14
13. Lugano, R., E. Peña, L. Badimon, and T. Padró. 2012. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinasetype plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell. J. Thromb. Haemost. 10: 2158-2167
14. Svensson, P. A., F. J. Olson, D. A. Hägg, M. Ryndel, O. Wiklund, L. Karlström, J. Hulthe, L. M. Carlsson, and B. Fagerberg. 2008. Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis. Int. J. Mol. Med. 22: 459-464
15. Hovius, J. W. R., M. F. Bijlsma, G. J. W.Van Der Windt, W. J. Wiersinga, B. J. D. Boukens, J. Coumou, A. Oei, R. De Beer, A. F. De Vos, C. Van ?t Veer, et al. 2009. The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi. PLoS Pathog. 5: E1000447
16. Wiersinga, W. J., L. M. Kager, J. W. R. Hovius, G. J. W.Van Der Windt, A. F. De Vos, J. C. M. Meijers, J. J. Roelofs, A. Dondorp, M. Levi, N. P. Day, et al. 2010. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. J. Immunol. 184: 3079-3086
17. Park, Y. J., G. Liu, Y. Tsuruta, E. Lorne, and E. Abraham. 2009. Participation of the urokinase receptor in neutrophil efferocytosis. Blood 114: 860-870
18. D?mello, V., S. Singh, Y. Wu, and R. B. Birge. 2009. The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells. J. Biol. Chem. 284: 17030-17038
19. Blasi, F., and N. Sidenius. 2009. Efferocytosis: Another function of uPAR. Blood 114: 752-753
20. Higazi, A. A., A. Mazar, J. Wang, N. Quan, R. Griffin, R. Reilly, J. Henkin, and D. B. Cines. 1997. Soluble human urokinase receptor is composed of two active units. J. Biol. Chem. 272: 5348-5353
21. Kunapuli, S. P., R. A. DeLa Cadena, and R. W. Colman. 1993. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains. J. Biol. Chem. 268: 2486-2492
22. Hasan, A. A., D. B. Cines, H. Herwald, A. H. Schmaier, and W. Muller-Esterl. 1995. Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270: 19256-19261
23. Herwald, H., A. A. Hasan, J. Godovac-Zimmermann, A. H. Schmaier, and W. Muller-Esterl. 1995. Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270: 14634-14642
24. Dai, J. H., Y. Iwatani, T. Ishida, H. Terunuma, H. Kasai, Y. Iwakula, H. Fujiwara, and M. Ito. 2001. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology 103: 235-243
25. Yeung, T., G. E. Gilbert, J. Shi, J. Silvius, A. Kapus, and S. Grinstein. 2008. Membrane phosphatidylserine regulates surface charge and protein localization. Science 319: 210-213
26. Martinez, J., J. Almendinger, A. Oberst, R. Ness, C. P. Dillon, P. Fitzgerald, M. O. Hengartner, and D. R. Green. 2011. Microtubule-associated protein 1 light chain 3 a (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc. Natl. Acad. Sci. USA 108: 17396-17401
27. Khan, M. M. H., S. P. Kunapuli, Y. Lin, A. Majluf-Cruz, R. A. D. Cadena, S. L. Cooper, and R. W. Colman. 1998. Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils. Am. J. Physiol. 275: H145-H150
28. Morelli, A. E., A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo, Jr., and A. W. Thomson. 2003. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood 101: 611-620
29. Wang, S., G. L. Dale, P. Song, B. Viollet, and M. H. Zou. 2010. AMPKalpha1 deletion shortens erythrocyte life span in mice: Role of oxidative stress. J. Biol. Chem. 285: 19976-19985
30. Wu, Y., V. Rizzo, Y. Liu, I. M. Sainz, N. G. Schmuckler, and R. W. Colman. 2007. Kininostatin associates with membrane rafts and inhibits a(v)beta3 integrin activation in human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27: 1968-1975
31. Colman, R. W., R. A. Pixley, S. Najamunnisa, W. Yan, J. Wang, A. Mazar, and K. R. McCrae. 1997. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100: 1481-1487
32. Blasi, F., and N. Sidenius. 2010. The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett. 584: 1923-1930
33. Pixley, R. A., Y. Lin, I. Isordia-Salas, and R. W. Colman. 2003. Fine mapping of the sequences in domain 5 of high molecular weight kininogen (HK) interacting with heparin and zinc. J. Thromb. Haemost. 1: 1791-1798
34. Kjøller, L., and A. Hall. 2001. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152: 1145-1157
35. Smith, H. W., P. Marra, and C. J. Marshall. 2008. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. J. Cell Biol. 182: 777-790
36. Park, D., A. C. Tosello-Trampont, M. R. Elliott, M. Lu, L. B. Haney, Z. Ma, A. L. Klibanov, J. W. Mandell, and K. S. Ravichandran. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450: 430-434
37. Anderson, H. A., C. A. Maylock, J. A. Williams, C. P. Paweletz, H. Shu, and E. Shacter. 2003. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4: 87-91
38. Sugi, T., and J. A. McIntyre. 1995. Autoantibodies to phosphatidylethanolamine( PE) recognize a kininogen-PE complex. Blood 86: 3083-3089
39. Barbasz, A., I. Guevara-Lora, M. Rapala-Kozik, and A. Kozik. 2008. Kininogen binding to the surfaces of macrophages. Int. Immunopharmacol. 8: 211-216
40. Chavakis, T., S. M. Kanse, R. A. Pixley, A. E. May, I. Isordia-Salas, R. W. Colman, and K. T. Preissner. 2001. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 15: 2365-2376
41. Khan, M. M., H. N. Bradford, I. Isordia-Salas, Y. Liu, Y. Wu, R. G. Espinola, B. Ghebrehiwet, and R. W. Colman. 2006. High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler. Thromb. Vasc. Biol. 26: 2260-2266
42. Pixley, R. A., R. G. Espinola, B. Ghebrehiwet, K. Joseph, A. Kao, K. Bdeir, D. B. Cines, and R. W. Colman. 2011. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Thromb. Haemost. 105: 1053-1059
43. Tesfay, L., A. J. Huhn, H. Hatcher, F. M. Torti, and S. V. Torti. 2012. Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. PLoS ONE 7: E40030
44. del Pozo, M. A., N. B. Alderson, W. B. Kiosses, H. H. Chiang, R. G. Anderson, and M. A. Schwartz. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science 303: 839-842
45. Wei, C., C. C. Möller, M. M. Altintas, J. Li, K. Schwarz, S. Zacchigna, L. Xie, A. Henger, H. Schmid, M. P. Rastaldi, et al. 2008. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14: 55-63
46. Furlan, F., C. Galbiati, N. R. Jorgensen, J-E. B. Jensen, E. Mrak, A. Rubinacci, F. Talotta, P. Verde, and F. Blasi. 2007. Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J. Bone Miner. Res. 22: 1387-1396
47. Tjwa, M., N. Sidenius, R. Moura, S. Jansen, K. Theunissen, A. Andolfo, M. De Mol, M. Dewerchin, L. Moons, F. Blasi, et al. 2009. Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J. Clin. Invest. 119: 1008-1018
48. May, A. E., S. M. Kanse, L. R. Lund, R. H. Gisler, B. A. Imhof, and K. T. Preissner. 1998. Urokinase receptor (CD87) regulates leukocyte recruitment via b 2 integrins in vivo. J. Exp. Med. 188: 1029-1037
49. Olson, F. J., T. Thurison, M. Ryndel, G. Høyer-Hansen, and B. Fagerberg. 2010. Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability. Clin. Biochem. 43: 124-130
50. Frick, I. M., P. Akesson, H. Herwald, M. Mörgelin, M. Malmsten, D. K. Nägler, and L. Björck. 2006. The contact system-a novel branch of innate immunity generating antibacterial peptides. EMBO J. 25: 5569-5578
51. Maas, C., J. W. Govers-Riemslag, B. Bouma, B. Schiks, B. P. Hazenberg, H. M. Lokhorst, P. Hammarström, H. ten Cate, P. G. De Groot, B. N. Bouma, and M. F. Gebbink. 2008. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J. Clin. Invest. 118: 3208-3218
52. Van Der Meijden, P. E., I. C. Munnix, J. M. Auger, J. W. Govers-Riemslag, J. M. Cosemans, M. J. Kuijpers, H. M. Spronk, S. P. Watson, T. Renné, and J. W. Heemskerk. 2009. Dual role of collagen in factor XII-dependent thrombus formation. Blood 114: 881-890
53. Muller, F., N. J. Mutch, W. A. Schenk, S. A. Smith, L. Esterl, H. M. Spronk, S. Schmidbauer, W. A. Gahl, J. H. Morrissey, and T. Renné. 2009. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139: 1143-1156